These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21376731)

  • 21. Formation of highly toxic soluble amyloid beta oligomers by the molecular chaperone prefoldin.
    Sakono M; Zako T; Ueda H; Yohda M; Maeda M
    FEBS J; 2008 Dec; 275(23):5982-93. PubMed ID: 19021772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
    Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
    Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alzheimer beta-amyloid peptides: structures of amyloid fibrils and alternate aggregation products.
    Gorman PM; Chakrabartty A
    Biopolymers; 2001; 60(5):381-94. PubMed ID: 12115148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis.
    Jaikaran ET; Higham CE; Serpell LC; Zurdo J; Gross M; Clark A; Fraser PE
    J Mol Biol; 2001 May; 308(3):515-25. PubMed ID: 11327784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibril formation of hsp10 homologue proteins and determination of fibril core regions: differences in fibril core regions dependent on subtle differences in amino acid sequence.
    Yagi H; Sato A; Yoshida A; Hattori Y; Hara M; Shimamura J; Sakane I; Hongo K; Mizobata T; Kawata Y
    J Mol Biol; 2008 Apr; 377(5):1593-606. PubMed ID: 18329043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of beta-sheets in Alzheimer's beta-amyloid fibrils.
    Antzutkin ON; Balbach JJ; Leapman RD; Rizzo NW; Reed J; Tycko R
    Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13045-50. PubMed ID: 11069287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lysozyme amyloidogenesis is accelerated by specific nicking and fragmentation but decelerated by intact protein binding and conversion.
    Mishra R; Sörgjerd K; Nyström S; Nordigården A; Yu YC; Hammarström P
    J Mol Biol; 2007 Feb; 366(3):1029-44. PubMed ID: 17196616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations alter the geometry and mechanical properties of Alzheimer's Aβ(1-40) amyloid fibrils.
    Paparcone R; Pires MA; Buehler MJ
    Biochemistry; 2010 Oct; 49(41):8967-77. PubMed ID: 20731379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A strategy for designing a peptide probe for detection of β-amyloid oligomers.
    Hu Y; Su B; Kim CS; Hernandez M; Rostagno A; Ghiso J; Kim JR
    Chembiochem; 2010 Nov; 11(17):2409-18. PubMed ID: 21031399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of protein sequence and amino acid composition in amyloid formation: scrambling and backward reading of IAPP amyloid fibrils.
    Sabaté R; Espargaró A; de Groot NS; Valle-Delgado JJ; Fernàndez-Busquets X; Ventura S
    J Mol Biol; 2010 Nov; 404(2):337-52. PubMed ID: 20887731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The binding of thioflavin-T to amyloid fibrils: localisation and implications.
    Krebs MR; Bromley EH; Donald AM
    J Struct Biol; 2005 Jan; 149(1):30-7. PubMed ID: 15629655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review: history of the amyloid fibril.
    Sipe JD; Cohen AS
    J Struct Biol; 2000 Jun; 130(2-3):88-98. PubMed ID: 10940217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of dendrimer's structure on its activity against amyloid fibril formation.
    Klajnert B; Cortijo-Arellano M; Cladera J; Bryszewska M
    Biochem Biophys Res Commun; 2006 Jun; 345(1):21-8. PubMed ID: 16674918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucagon fibril polymorphism reflects differences in protofilament backbone structure.
    Andersen CB; Hicks MR; Vetri V; Vandahl B; Rahbek-Nielsen H; Thøgersen H; Thøgersen IB; Enghild JJ; Serpell LC; Rischel C; Otzen DE
    J Mol Biol; 2010 Apr; 397(4):932-46. PubMed ID: 20156459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conformation-dependent single-chain variable fragment antibodies specifically recognize beta-amyloid oligomers.
    Wang XP; Zhang JH; Wang YJ; Feng Y; Zhang X; Sun XX; Li JL; Du XT; Lambert MP; Yang SG; Zhao M; Klein WL; Liu RT
    FEBS Lett; 2009 Feb; 583(3):579-84. PubMed ID: 19162022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-amyloid fibril formation is promoted by step edges of highly oriented pyrolytic graphite.
    Losic D; Martin LL; Aguilar MI; Small DH
    Biopolymers; 2006; 84(5):519-26. PubMed ID: 16752395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
    Meli G; Visintin M; Cannistraci I; Cattaneo A
    J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design of peptides that form amyloid-like fibrils capturing amyloid beta1-42 peptides.
    Sato J; Takahashi T; Oshima H; Matsumura S; Mihara H
    Chemistry; 2007; 13(27):7745-52. PubMed ID: 17605154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro characterization of lactoferrin aggregation and amyloid formation.
    Nilsson MR; Dobson CM
    Biochemistry; 2003 Jan; 42(2):375-82. PubMed ID: 12525164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural disorder in amyloid fibrils: its implication in dynamic interactions of proteins.
    Tompa P
    FEBS J; 2009 Oct; 276(19):5406-15. PubMed ID: 19712107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.